✦ LIBER ✦

The role of promoter hypermethylation in fibroblast activation and fibrogenesis

✍ Scribed by Zeisberg, Elisabeth M; Zeisberg, Michael

Book ID: 118765538
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 280 KB
Volume: 229
Category: Article
ISSN: 0022-3417
DOI: 10.1002/path.4120

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypermethylation of the hTERT promoter i

Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes

✍ Shin, K-H; Kang, M K; Dicterow, E; Park, N-H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB

Role of prostaglandins in fibroblast act

Role of prostaglandins in fibroblast activation and fibrosis

✍ Richard Stratton; Xu Shiwen 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 93 KB

The role of aberrant promoter hypermethy

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma

✍ Huan Cheng; Zhonglei Deng; Zengjun Wang; Wei Zhang; Jiantang Su 📂 Article 📅 2012 🏛 Journal of Biomedical Research 🌐 English ⚖ 612 KB

The role of p161NK4A promoter hypermethy

The role of p161NK4A promoter hypermethylation during neoplastic progression in Barrett's esophagus

✍ Klump, B.; Hsieh, CJ; Holzmann, K.; Gregor, M.; Porschen, R. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 178 KB

230. The role of promoter hypermethylati

230. The role of promoter hypermethylation and expression of spleen tyrosine kinase in mammary carcinogenesis

✍ O-charoenrat, P.; Thakrairach, B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Role of ERCC1 promoter hypermethylation

Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas

✍ Hua-Yun Chen; Cui-Jie Shao; Fu-Rong Chen; Aij-Lie Kwan; Zhong-Ping Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 523 KB

## Abstract Overexpression of ERCC1 mRNA is associated with drug resistance to cisplatin in human gliomas, but the role of the ERCC1 promoter in drug resistance has not been demonstrated. We have used sodium bisulfite sequencing to compare ERCC1 promoter methylation patterns in cisplatin‐sensitive